Where does Adam S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adam S.A. ranks #44,401 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adam S.A. hold?

Adam S.A. holds 5 US utility patents granted between 2016 and 2022, spanning 6 technology areas.

What is Adam S.A.'s Innovation Score?

Adam S.A. has an Innovation Score of 35.1 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Adam S.A.'s patent grant rate increasing or decreasing?

Adam S.A.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Adam S.A.'s patents?

Adam S.A.'s patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adam S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Adam S.A.

Q: What technology areas does Adam S.A. focus on?

Adam S.A.'s top technology area is H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams) with 5 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adam ranks #44,401 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#44,401
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.1/100): 11.6
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44401 · Foreign Corporation #44,401 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,401/49,997
PHOTO-FINISH Activus Pharma
CPC-NARROW H05H · 6 areas
INNOV-THIN 35.1/100
CLAIMS-PAR 11.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Activus Pharma Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Acea Biosciences · near

35
Adam · this assignee

35
Anchor Wall Systems · near

35
Camelot UK Bidco · near

35
Realpage · near

35
3D Lighting… · lowest

7

What this shows Adam's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Adam's grants concentrate

Adam S.A. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Adam sits between Activus Pharma Co., Ltd. and Adco Industries—Technologies, L.P..

Adam's three-year grant acceleration

Adam S.A. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Activus Pharma

5
Actv8

5
Acumen

5
ADA Support

5
Adapt Solutions

5
Adaptive Computat…

5
ADC Acquisition

5
Adco Industries—

5
Adam ◀

5

What this shows Adam holds 5 patents at rank #44,387, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adam

By rank, the assignees closest to #44,387 in granted patent volume.

Leaders in H05H (Plasma Technique)

Other assignees with the most granted patents in Adam's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Adam, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Realpage, Inc. 35 Camelot UK Bidco Limited 35 Acea Biosciences, Inc. 35 Anchor Wall Systems, Inc. 35

Adam's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Adam S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2017	1	20.0%
2020	1	20.0%
2022	2	40.0%

Which technologies does Adam S.A. patent most?

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

G01T - Measurement OF Nuclear OR X-radiation 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#44,401

of 49,997 tracked assignees

Innovation Score

35.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Adam S.A.'s patent record in context - here's where to go next.

Adam S.A.'s lead technology class is H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams), 100% of its portfolio - see every assignee active in that class. Explore H05H
Ranked #44,401 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adam S.A. against Activus Pharma Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.